Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Clinical Therapeutics|January 19, 2008
Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort studyXin Ye, Cynthia R Gross, Jon Schommer, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 17, 2014
Utilization and costs of medications associated with CKD mineral and bone disorder in dialysis patients enrolled in Medicare Part DAkeem A Yusuf, Benjamin L Howell, Christopher A Powers, et al.
Kidney Medicine|January 3, 2023
Disparities in SGLT2 Inhibitor or Glucagon-Like Peptide 1 Receptor Agonist Initiation Among Medicare-Insured Adults With CKD in the United StatesJulie Z Zhao, Eric D Weinhandl, Angeline M Carlson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 10, 2012
Finding a common language for patient safety in CKDJeffrey C Fink, Melanie S Joy, Wendy L St Peter, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2005
Trends in intravenous iron use among dialysis patients in the United States (1994-2002)Wendy L St Peter, Gregorio T Obrador, Tricia L Roberts, et al.
Kidney Medicine|April 14, 2021
Glucose-Lowering Medication Use in CKD: Analysis of US Medicare Beneficiaries Between 2007 and 2016Julie Z Zhao, Eric D Weinhandl, Angeline M Carlson, et al.
Nephrology News & Issues|December 30, 2011
Medicare Part D: challenges for dialysis patients. Part 1Stephanie Smith, Beth Witten, Catherine Paykin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 28, 2010
Trends in parathyroidectomy rates in US hemodialysis patients from 1992 to 2007Suying Li, Yen-Wen Chen, Yi Peng, et al.
Drugs|June 7, 2017
A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?Wendy L St. Peter, Lori D Wazny, Eric Weinhandl, et al.
Kidney International|November 18, 2011
Issues regarding 'immortal time' in the analysis of the treatment effects in observational studiesJiannong Liu, Eric D Weinhandl, David T Gilbertson, et al.
Pageof 8